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ABSTRACT
Background: Endovascular treatment has revolutionized the 
therapeutic approach to abdominal aortic aneurysms due to 
its low morbidity and mortality rates. Despite technological 
advances, there are still anatomical limitations to the use of 
stent grafts. This study aimed to evaluate the immediate clinical 
results in patients with complex abdominal aortic aneurysms 
treated with a second-generation stent graft. Methods: 
This was an observational, prospective, non-randomized, 
single-centre study with a series of patients who underwent 
endovascular repair of complex infra-renal abdominal aortic 
aneurysms using a stent graft with a dual-ring stent design 
(AnacondaTM, Vascutek – Terumo, Inchinnan, Scotland). Clinical 
and angiographic characteristics, technical and therapeutic 
success rates, morbidity and mortality, and perioperative re-
intervention rates were evaluated. Results: Between February 
2010 and December 2011, 108 consecutive patients with 
aortic aneurysms were treated; 16 had complex abdominal 
aortic aneurysms treated with the AnacondaTM AAA Stent 
Graft System. The mean age was 76  ±  7 years and 75% 
were males. Technical success was observed in 94% of 
the cases and therapeutic success was achieved in 75% 
of the cases. There was one postoperative death. The most 
prevalent perioperative complications were surgical wound 
bleeding (2/16) and peripheral embolism (2/16). Reinterven-
tions were required in 12.5% of the patients during follow-up. 
Conclusions: In this study, the second-generation AnacondaTM 
Stent Graft System was effective and provided satisfactory 
immediate results in the treatment of complex infra-renal 
abdominal aortic aneurysms. 
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RESUMO
Tratamento Endovascular dos Aneurismas da  
Aorta Abdominal com Anatomia Complexa:  
Resultados Preliminares com a Segunda Geração  
de Endoprótese com Arcabouço Metálico Circular
Introdução: O tratamento endovascular dos aneurismas da aorta 
abdominal tem revolucionado o tratamento dessa afecção, em 
decorrência das baixas taxas de morbidade e mortalidade. Apesar 
dos avanços tecnológicos ocorridos nas endopróteses, ainda existem 
limitações anatômicas para o emprego da técnica. Este estudo 
teve por objetivo avaliar os resultados imediatos do tratamento 
de pacientes portadores de aneurisma da aorta abdominal com 
anatomia complexa com uma endoprótese de segunda geração. 
Métodos: Estudo observacional, prospectivo, não randomizado, 
realizado em um único centro, em uma série de pacientes 
submetidos a tratamento endovascular de aneu rismas da aorta 
abdominal infrarrenais complexos, com prótese com arcabouço 
metálico disposta em anéis (AnacondaTM – Vascutek, Terumo, 
Inchinnan, Escócia). Foram avaliados as características clínicas e 
angiográficas, o sucesso técnico, o sucesso terapêutico, a morbi-
dade e a mortalidade, e a taxa de reintervenção perioperatória. 
Resultados: Foram analisados, no período de fevereiro de 2010 
a dezembro de 2011, 108 pacientes consecutivos portadores de 
aneurisma da aorta, dos quais 16 eram portadores de aneurisma 
da aorta abdominal com anatomia complexa tratados com a 
prótese AnacondaTM. A média de idade foi de 76 ± 7 anos 
e 75% eram do sexo masculino. Houve sucesso técnico em 
94% e êxito terapêutico em 75% dos casos. Ocorreu um óbito 
no pós-operatório. As complicações perioperatórias mais preva-
lentes foram sangramento da ferida operatória (2/16) e embolia 
periférica (2/16). Foram necessárias reintervenções em 12,5% dos 
pacientes durante o seguimento. Conclusões: Neste estudo, a se-
gunda geração da endoprótese AnacondaTM foi efetiva e apresenta 
resultados imediatos satisfatórios no tratamento do aneurisma da 
aorta abdominal infrarrenal de anatomia complexa.
DESCRITORES: Aneurisma da aorta abdominal. Prótese vascu lar. 
Arteriosclerose. Aterosclerose.
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F or many years, surgical treatment has been the standard therapy for patients with abdominal aortic aneurysm.1 Since the introduction of the endovas-
cular repair technique by Parodi et al.2 in 1991, which 
aimed to decrease intra- and postoperative morbidity 
and mortality, the materials used for this treatment have 
been constantly improved. These improvements have 
led to better medium and long-term results.3
Endovascular repair is preferably indicated for 
high-risk surgical patients due to clinical comorbidi-
ties or for those patients with anatomic difficulties for 
an open surgical approach (hostile abdomen). Despite 
aggressive technological development, the ideal endograft 
has not yet been designed, and there are still technical 
limitations regarding the percutaneous procedure due to 
local anatomic variation, which hinders the adequate 
exclusion of the aneurysm.
Three major studies (Comparison of EndoVascular 
Aneurysm Repair open repair in patients with abdominal 
aortic aneurysm – EVAR 1, Endovascular Aneurysm Repair 
and outcome in patients unfit for open repair of abdomi-
nal aortic aneurysm – EVAR 2, and Dutch Randomized 
Endovascular Aneurysm Management – DREAM)4–6 have 
shown that perioperative morbidity and mortality rates 
(within 30 days after the procedure) were favourable for 
endovascular treatment; however, when mortality rates 
were compared with that of the surgical technique, they 
were similar after one year of aneurysm treatment. The 
reintervention rates were greater in the endovascular 
treatment group and varied from 14% to 26%. This fact 
motivated the development of more versatile and flexible 
endografts, which would better adapt to existing anatomic 
obstacles in the aneurysm neck and aortoiliac bifurcation, 
as well as promote better sealing of its connections. A 
better seal would help prevent undesired endoleaks and 
decrease reintervention rates. 
The aim of this study was to conduct an analysis 
of the perioperative results achieved through the use of 
a second-generation stent graft with a dual-ring stent 
design (AnacondaTM, Vascutek – Terumo, Inchinnan, 
Scotland) in the treatment of complex infra-renal ab-
dominal aortic aneurysms. 
METHODS
This was an observational, prospective, non-randomized 
study conducted at a cardiovascular disease centre in the 
state of São Paulo between February of 2010 and December 
of 2011. During the study period, 108 consecutive patients 
with aortic aneurysms were percutaneously treated with 
the AnacondaTM second-generation stent graft; 16 patients 
had complex infra-renal abdominal aortic aneurysms.
Inclusion and exclusion criteria
Patients with abdominal aortic aneurysm and indi-
cation for elective repair using the diameter criterion 
(> 55 mm in men and > 50 mm in women) or due to 
the presence of symptoms were included in the study. 
The anatomical criteria for using the stent graft were 
the presence of angulation in the proximal aortic neck 
(defined as the angle between the greater axis of the 
aneurysm neck and the greater axis of the aneurysm) 
and/or aortoiliac bifurcation of >  60 degrees. The 
study excluded patients presenting with a proximal 
neck <  15  mm, thrombus, calcification >  50% of the 
neck circumference, diameter of external iliac arteries 
<  7  mm, serum creatinine >  2  mg/dL, or creatinine 
clearance <  30  mL/min. 
Techniques used
The diagnosis and treatment of abdominal aortic 
aneurysm were based on angio-tomography, employ-
ing a 64-channel multi-slice computed tomography 
scan with 1  mm slices in all cases. Preoperative 
arte riography was an optional diagnostic method. All 
computed tomography scans were reproduced using 
OSIRIX® software in 3D and multi-planar reconstruction 
(MPR) modes. Therefore, it was possible to obtain the 
diameters, angles, and lengths of the proximal aortic 
neck, aneurysm, and aortoiliac bifurcation (Figure 1). 
AnacondaTM is a tri-modular stent graft consisting 
of a nitinol dual-ring design and coated with woven 
Dacron. The proximal part of the graft body consists 
of two nitinol rings that provide radial strength for 
passive sealing of the proximal neck. Active fixation is 
provided by four pairs of hooks (two anterior pairs and 
two lateral pairs), which are not required for suprarenal 
or juxta-renal fixation. The stent graft diameter must be 
10% to 20% greater than the internal diameter of the 
proximal aortic neck. The main body is connected to 
a system of nitinol rings, which make it possible for 
the stent graft to be collapsed and repositioned. The 
iliac leg consists of a woven Dacron® prosthesis with a 
series of nitinol rings whose distance varies according 
to its diameter. The contralateral iliac leg is connected 
through catheterization and is facilitated by a magnetic 
guide wire connected to the body of the stent graft. 
Dilation with a compliant balloon during the operation 
is only recommended in the case of an initial endoleak, 
and should not be frequently performed.
All procedures were performed in a haemodynamic 
monitoring laboratory. Patients were treated under gen-
eral inhalation anaesthetics. Antimicrobial prophylaxis 
was administered with 1.5 g of cefuroxime at the mo-
ment of anaesthesia induction. The preferred approach 
was by the bilateral common femoral artery through 
open surgical dissection. When this approach was not 
possible, the external iliac artery was accessed via a 
retroperitoneal approach.
Radiographic control was performed with the 
Artis® Flat Panel detector (Siemens, Munich, Germany). 
When the location of the device was not considered 
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Figure 1 – Angio-tomography showing a three-dimensional multi-planar reconstruction of a complex aortic aneurysm. A shows a 30-mm diameter 
aortic neck. B shows the neck angle (71  degrees). C shows the greatest diameter of the aneurysm (75  mm). D shows the angle of the aortoiliac 
bifurcation (82  degrees). E shows the length of the right common iliac artery (46  mm). F shows a three-dimensional reconstruction (anterior view). 
G shows a three-dimensional reconstruction (posterior view). 
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satisfactory during the positioning of the proximal neck, 
the device was repositioned in the craniocaudal direc-
tion or according to its longitudinal axis. When the 
first stage was finished, the contralateral iliac leg was 
introduced after magnetic catheterization of the stent 
body and then released. When the second stage was 
finished, the catheterization of the ipsilateral leg was 
performed, which was finally released and fixed to the 
stent body. Intraoperative arteriography was performed 
in all patients (Figure 2). All patients were transferred to 
the intensive care unit immediately after the procedure. 
Outpatient follow-up occurred 15 and 30 days 
after the procedure. Angio-tomography was performed 
on the 30th day of outpatient follow-up. Colour-Doppler 
ultrasound was performed when angio-tomography was 
contraindicated. 
Definitions
Complex infra-renal abdominal aortic aneurysms 
present with a proximal aortic neck and/or aortoiliac 
bifurcation >  60  degrees. Initial or primary endoleaks 
were defined as those occurring during the initial 
procedure or those diagnosed within the first 30 days. 
Technical success was achieved with the release 
of the stent graft in the affected area, regardless of the 
presence of endoleaks or other incidents that could 
negatively influence the outcome. Therapeutic success was 
achieved when the release of the stent graft occurred 
without endoleaks or other incidents that could influence 
clinical outcomes of the patients. 
Peri-procedural complications were classified as 
intraoperative complications when they occurred during 
the intervention procedure in the haemodynamic 
monitoring room, and were classified as perioperative 
complications when they occurred during the hospital 
stay, outside the hemodynamic monitoring room, and 
within 30 days after intervention. The following were 
considered complications: local bleeding (presence of 
inguinal or retroperitoneal haematoma); uni- or bilateral 
occlusion of the renal arteries; presence of peripheral 
embolization causing acute arterial occlusion; pres-
ence of mesenteric ischemia causing vascular acute 
abdomen; infections (whether surgical site infections 
or lower respiratory tract infections); acute renal fail-
ure (>  two times the increase in the basal creatinine 
before the procedure); occlusion of the stent graft due 
to thrombosis; and death. 
Reintervention was defined as an intervention 
performed to maintain the appropriate function of the 
stent graft and exclude the aneurysm sac, or to resolve 
complications related to the initial intervention. 
In-hospital lenght of stay was defined as the time 
period between hospital admission and discharge. 
Procedure time was defined as the period between the 
beginning of anaesthesia induction and the closure of 
the operative surgical site. 
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Figure 2 – A shows an angio-tomography of the complex abdominal aortic aneurysm with a proximal aneurysm neck angle >  60  degrees and aor-
toiliac bifurcation >  90  degrees. B shows the endovascular repair with an AnacondaTM stent graft.
RESULTS
All patients were asymptomatic, and were electively 
treated. The average duration of the procedure was 112 
minutes (varying from 76 minutes to 155 minutes), and 
the average in-hospital length of stay period was 4.2 
days (minimum: three days; maximum: 14 days). 
Sixteen patients who underwent a complex infra-
renal abdominal aortic aneurysm repair were analysed. 
The mean age was 76  ±  7 years, and 75% of the 
patients were male (Table 1). Among the co-morbidities, 
the incidence of coronary artery disease was 43.7%, 
chronic obstructive pulmonary disease was 37.5%, and 
chronic renal failure was 18.7%. Half of the population 
were ASA surgery risk ≥ 3 (according to the criteria of 
the American Society of Anesthesiology).
In all cases, aneurysm morphology was fusiform. The 
types of aneurysm treated according to the classifica-
tion used by the European Collaborators on Stent/graft 
Techniques for Aortic Aneurysm Repair (EUROSTAR)7 
(Figure 3) were: type D in four patients (25%), type 
F in six patients (37.5%) and type G in six patients 
(37.5%). Table 2 shows the average diameter of the 
aneurysm and the characteristics of the proximal neck 
and the aortoiliac bifurcation.
The tri-modular pattern of the stent graft was used 
in all cases. It was necessary to use unilateral extensions 
in five (31.2%) of the patients and bilateral extensions 
in four (25%) of the patients. Stent graft repositioning 
was performed in three cases (18.6%). 
Technical success was achieved in 94%; it was 
possible to release the stent graft at the desired site in 
15 patients. In one case it was necessary to convert 
TABLE 1 
Clinical Data
Characteristics of the population n = 16
Age, years 76 ± 7
Male gender, n (%) 12 (75)
Asymptomatic disease, n (%) 16 (100)
Severe obesity (BMI > 40 kg/m2), n (%) 1 (6.2)
Active tobacco smoking, n (%) 5 (31.2)
Diabetes mellitus, n (%) 4 (25)
Arterial hypertension, n (%) 15 (93.7)
Dyslipidemia, n (%) 12 (75)
BMI = body mass index; n = number of patients.
to an open surgical approach. Therapeutic success 
was observed in 75% of the cases; in 12 patients the 
stent graft was released without an endoleak or other 
incidents that could negatively influence the outcome.
In three cases (18.7%), it was necessary to embolize 
the hypogastric artery during the procedure in order to 
anchor the iliac leg of the stent graft or its extension in 
the ipsilateral external iliac artery. There were no cases 
of pelvic or intestinal ischemia, erectile dysfunction, or 
buttock claudication at follow-up. 
The complication rate was 31.2%, and the most 
frequent intraoperative complications were operative site 
bleeding in two cases (12.5%), peripheral embolism in 
two cases (12.5%), and occlusion of the bilateral renal 
arteries in one case (6.2%), which required conversion 
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Figure 3 – Classification of abdominal aortic aneurysms – EUROSTAR. (Adapted from Harris et al.7).
A B C D
E F G
to open surgery. Perioperative infection occurred in 
one case (6.2%). This was an operative site infection 
that was treated with the use of systemic antibiotics 
without clinical repercussions for the patient (Table 3). 
Perioperative mortality was 6.2%. Despite conversion to 
an open surgery, one patient died because the bilateral 
renal arteries were occluded due to stent body migration 
during the operation. 
The total endoleak rate was 31.2%, and type I 
and II endoleaks were present in 25% (Table 4). The 
perioperative reintervention rate was 12.5% due to the 
treatment of 2 type Ib endoleaks. One patient with 
a type Ia endoleak was treated during the operation 
by insufflating the compliant balloon in the proximal 
neck, which led to resolution of the endoleak. A type 
III endoleak, which is caused by inappropriate sealing 
of the anchoring zone of the iliac legs, was treated in 
the same way. A type II endoleak, with branches fill-
ing the aneurysm sac, was observed in one case on 
postoperative angio-tomography. Additional interven-
tions due to an increase in the size of the aneurysm 
sac were not necessary. Two reinterventions to treat a 
type Ib endoleak and the endoleak of the stent graft 
iliac leg were necessary; iliac leg extensions were used 
after surgery. 
TABLE 2 
Angiographic Characteristics
Characteristics
Aneurysm diameter, mm 71 ± 16
Morphological classification, n (%)
Type D
Type F
Type G
4 (25)
6 (37.5)
6 (37.5)
Aortic neck diameter, mm  
(variation)
22 (19–30)
Aortic neck length, mm  
(variation)
19 (15–26)
Calcification or thrombus in the 
aortic neck*, n (%)
3 (18.7)
Angle of the proximal aortic neck, 
degrees
75 ± 15
Angle of the aortoiliac bifurcation, 
degrees
80 ± 25
*Affecting 25% to 50% of the circumference. 
n = number of patients.
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DISCUSSION
Endovascular treatment of abdominal aortic aneu-
rysms is a less invasive alternative compared to open 
surgery, and it is indicated for high-risk patients and 
for those with appropriate anatomy.8 Open surgery 
is associated with a mortality rate of 2% to 6%. A 
mortality rate of 2% is associated with low-risk cases, 
but the mortality can be as high as 50% in cases of 
ruptured aneurysms.9 According to several publica-
tions, technological innovations and the experience 
gained with the use of endovascular techniques over 
the last 20 years have reduced the mortality rate 
and have led to results that are similar to or even 
better than those observed with traditional surgical 
treatment.4–6,10–13 
Not all patients can undergo endovascular 
treatment, and unfavourable anatomy is the main 
limitation to using this technique. These limitations 
must be evaluated individually, taking into account 
the team’s experience, the characteristics observed 
on computed tomography, and the stent graft used. 
The most important anatomic features that determine 
endovascular treatment are the tortuosity of the aorta 
and the diameter, the length of the proximal neck 
(fixation area for the stent graft), and the access to 
the iliac-femoral segment. Secondary factors include 
angulation of the aorta (proximal neck) and iliac 
arteries, calcification, and the presence of mural 
thrombus in the proximal neck.14
Nowadays, endovascular treatment of abdominal 
aortic aneurysms with infra-renal fixation devices is 
recommended for aortas with an anchorage zone 
>  15  mm, a landing neck diameter <  32  mm, and 
an aortic neck angulation <  60 degrees.8 Stent grafts 
with suprarenal fixation have been indicated to provide 
better sealing to the proximal neck when its morphology 
is unfavourable due to the short length of the landing 
neck, severe angulation, extensive calcification, and 
mural thrombus. Despite the advantages of using stent 
grafts with suprarenal fixation for complex abdomi-
nal aortic aneurysms, it is still necessary to wait for 
long-term follow-up in order to document the incidence 
of embolization or renal occlusion.8,15 
The AnacondaTM stent graft is a device that uses 
infra-renal fixation and consists of a ring design that 
provides more flexibility and radial strength to adapt 
to landing necks with unfavourable anatomy. The easy 
manoeuvring of the delivery system and the hydrophilic 
coating facilitate navigation through tortuous iliac vessels. 
The repositionable deployment system enables position 
correction in the aortic neck. The catheterization system 
with the contralateral leg facilitates the procedure 
in patients with pronounced aortoiliac angulations. 
These features make the stent graft more attractive for 
the treatment of more complex infra-renal abdominal 
aortic aneurysms. 
In a comparative study using aortic stent grafts in 
humans aimed at evaluating iliac and aortic fixation, 
Melas et al.16 verified the improved proximal fixation 
with the AnacondaTM stent graft versus six other stents 
from different manufacturers. The improved proximal 
fixation is due to the presence of four pairs of hooks 
and the nitinol coating, which provides greater radial 
strength and an improved proximal seal. 
The present study analysed 108 consecutive patients; 
16 had complex abdominal aortic aneurysms. Despite 
anatomic difficulties, technical success was achieved in 
94.1% of the cases. In one patient it was not possible 
to position and release the stent graft at the appropriate 
site, and surgical conversion was necessary. In this case, 
the degree of aortic tortuosity and calcification of the 
access arteries were underestimated. The literature reports a 
technical success rate of 94%–99%.13,17 In the EUROSTAR 
registry7 it was not possible to advance the delivery system 
TABLE 3 
Intra and Perioperative Complications
Intraoperative outcomes, n (%)
Death
Bleeding
Bilateral renal artery occlusion
Peripheral embolism
1 (6.2)
2 (12.5)
1 (6.2)
2 (12.5)
Perioperative outcomes, n (%)
Infection 
Acute renal failure
Occlusion of the stent graft iliac leg 
Mesenteric ischemia
1 (6.2)
1 (6.2)
1 (6.2)
0
n = number of patients.
TABLE 4 
Primary Endoleak Data
Type of Endoleak
Total, n (%) 5 (31.2)
Type Ia, n (%) 1 (6.2)
Type Ib, n (%) 2 (12.5)
Type II, n (%) 1 (6.2)
Type III, n (%) 1 (6.2)
Type IV, n (%) 0
n = number of patients.
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of the stent graft in 0.8% of the cases. Brazilian authors 
have published a study with 105 patients with abdominal 
aortic aneurysm undergoing endovascular repair, with a 
technical success rate of 97.2%.18 
In a study published by Perdikides et al.19 in 2009, 
the stent graft with a dual-ring design was used in 20 
patients with a complex abdominal aortic aneurysm 
and the technical success rate was 95%. The mean 
angulation of the aneurysms of these patients was 62 
degrees, the length of the proximal neck ranged from 
18  mm to 30  mm, and the average angulation of the 
aortoiliac bifurcation was 59 degrees. 
The initial technical success rate of the present 
study was 75%, which was calculated based on the 
incidence of endoleaks in the primary procedures. 
In the EUROSTAR registry,7 the incidence of an initial 
endoleak was 4.4% in type I, 9% in type II, and 2.4% 
in type III. In the population of this study, an initial 
endoleak was observed in 31.2% of the cases: 6.2% 
were type Ia (1 case), 12.5% (2 cases) were type Ib, 
6.2% (1 case) were type II, and 6.2% (1 case) were 
type III endoleaks. Analysing these statistics, four cases 
(25%) of type I and III endoleaks were observed. 
Of these, types Ia and III were resolved during the 
procedure by insufflating the balloon in the proximal 
neck in the case of the type Ia endoleak and by us-
ing the same technique in the iliac leg connection 
in the case of the type III endoleak. These endoleaks 
were considered primary endoleaks in this study, 
since post-dilation with a compliant balloon was not 
recommended during the initial procedure and was 
only performed in the case of an endoleak during the 
aneurysm repair. Angio-tomography performed one 
month after the procedure confirmed that there was 
no endoleak in these cases. The remaining two cases 
of type Ib endoleak were successfully treated with 
an extension of the iliac leg during the postoperative 
period, leading to a reintervention rate of 12.5%.
In a study performed by Freyrie et al.,3 49 patients 
with abdominal aortic aneurysm were treated with the 
AnacondaTM stent graft. They reported a technical suc-
cess rate of 100%, with no incidence of type I or II 
endoleak; 25% had a type II endoleak. In that study, 
most of the aneurysms had an aortic neck >  20  mm 
and a neck angle <  40 degrees. Other studies us-
ing the same stent graft showed a primary endoleak 
incidence rate of 10%, and a type I and II endoleak 
rate between 4.8% and 7.7%. All endoleaks showed 
favourable aortic anatomy.20
In the present study, the mortality rate within 30 
days of the procedure was 6.2%. A patient died during 
conversion to an open surgery due to occlusion of 
the renal arteries provoked by stent body migration 
during the procedure. In a Brazilian study, Palma et 
al.18 reported a mortality rate of 5.6% for patients who 
had an initial endovascular treatment for an abdominal 
aortic aneurysm.
The EVAR 1 study4 showed a 4.7% decrease in the 
perioperative mortality rate for open surgery versus 1.7% 
for endovascular treatment, a relative risk reduction 
of 65%. The EUROSTAR registry7 presented a 30-day 
mortality rate of 1.7% for minimally invasive treat-
ment, while the DREAM trial13 showed a perioperative 
mortality rate of 4.6% for open surgery and 1.2% for 
endovascular treatment. Brazilian authors showed a less 
significant decrease in the perioperative mortality rate 
of 6.5% and 5.5% for conventional and endovascular 
treatment, respectively.21,22 
According to May and White,23 approximately 
20% of the patients treated with an endovascular 
procedure develop intraoperative complications. Some 
of them are inversely proportional to the length of the 
aneurysm neck, that is, the smaller the aneurysm neck, 
the harder it is to position the endovascular device. 
At the same time, the greater the number of comorbi-
dities, the greater the risk of intra- and postoperative 
complications. The DREAM study,13 which compared 
operative mortality and complications after surgical 
treatment and endovascular treatment, concluded that 
endovascular treatment is more appropriate due to the 
lower mortality rate, the type of complications, and due 
to the significant reduction in systemic complications. 
The complication rate was 35% in the EVAR 1 study 
and 33% in the EVAR 2 study.4,6 
In this study, the total complication rate was 31.2% 
within 30 days after the procedure. Intraoperative 
bleeding at the surgical site occurred in two cases (two 
in the inguinal region, in which surgical intervention was 
not necessary) and peripheral embolization occurred in 
two cases (one case treated with embolectomy during 
surgery and the other case, a microembolism, treated with 
conservative management). These were the most frequent 
complications. Occlusion of an iliac leg was also observed. 
This was due to the presence of a calcified plaque close 
to the iliac extension, which led to thrombosis seven days 
after the surgery. The occlusion was successfully treated 
with a crossover femoro-femoral graft. 
Limitations of the study
The limitations of this study were the small sample 
size and the short follow-up, which limited the conclu-
sions and the possibility of comparing the results with 
more comprehensive studies. 
CONCLUSIONS
In this study, the second-generation stent graft with 
a dual-ring design was effective in the treatment of 
complex infra-renal abdominal aortic aneurysms. Studies 
Metzger et al.
Endovascular Treatment of Abdominal Aortic Aneurysms
Rev Bras Cardiol Invasiva. 
2012;20(1):69-76
76
with a greater number of patients and with medium-
and long-term follow-up may define its applicability. 
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